A detailed history of Fmr LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Fmr LLC holds 28,821,939 shares of NUVB stock, worth $66.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,821,939
Previous 27,737,077 3.91%
Holding current value
$66.3 Million
Previous $101 Million 16.64%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.58 - $3.69 $2.8 Million - $4 Million
1,084,862 Added 3.91%
28,821,939 $84.2 Million
Q1 2024

May 13, 2024

BUY
$1.46 - $3.97 $2.35 Million - $6.38 Million
1,606,418 Added 6.15%
27,737,077 $101 Million
Q4 2023

Feb 13, 2024

SELL
$0.96 - $1.53 $6.29 Million - $10 Million
-6,554,257 Reduced 20.05%
26,130,659 $39.5 Million
Q3 2023

Nov 13, 2023

BUY
$1.26 - $2.1 $18,091 - $30,151
14,358 Added 0.04%
32,684,916 $43.8 Million
Q2 2023

Aug 11, 2023

BUY
$1.56 - $1.84 $118 - $139
76 Added 0.0%
32,670,558 $58.8 Million
Q1 2023

May 11, 2023

BUY
$1.6 - $2.48 $9.83 Million - $15.2 Million
6,143,517 Added 23.16%
32,670,482 $54.2 Million
Q4 2022

Feb 13, 2023

SELL
$1.68 - $2.5 $5.58 Million - $8.31 Million
-3,322,498 Reduced 11.13%
26,526,965 $50.9 Million
Q3 2022

Nov 10, 2022

SELL
$0.29 - $4.04 $590,314 - $8.22 Million
-2,035,568 Reduced 6.38%
29,849,463 $66.9 Million
Q2 2022

Aug 12, 2022

BUY
$3.24 - $5.85 $927,624 - $1.67 Million
286,304 Added 0.91%
31,885,031 $103 Million
Q1 2022

May 13, 2022

SELL
$4.6 - $8.83 $309,639 - $594,373
-67,313 Reduced 0.21%
31,598,727 $166 Million
Q4 2021

Feb 14, 2022

SELL
$7.75 - $10.05 $3.6 Million - $4.66 Million
-464,134 Reduced 1.44%
31,666,040 $269 Million
Q3 2021

Nov 15, 2021

SELL
$7.78 - $10.0 $4.02 Million - $5.17 Million
-517,297 Reduced 1.58%
32,130,174 $319 Million
Q2 2021

Aug 13, 2021

BUY
$9.22 - $14.48 $301 Million - $473 Million
32,647,471 New
32,647,471 $304 Million

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $500M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.